3-(5,6-Difluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione, 98%, 100mg

[(5-ethyl-1,3,4-thiadiazol-2-yl)methyl]amine dihydrochloride, 95.0%, 5g

N,N'-(Disulfanediylbis(ethane-2,1-diyl))diacrylamide 98% stabilized with TBC, 98.0%, 25g

1,3-Bis[5-(4-tert-butylphenyl)-2-[1,3,4]oxadiazolyl]benzene>97.0%(HPLC)200mg

2,2'-(5'-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 97%, 10g

(3,4-Dihydroxyphenyl)(phenyl)methanone, 95.0%, 5g

3-hydroxy-7-nitro-2-oxo-1,2-dihydroquinoxaline-6-carbonitrile, 98%, 5mg

(2S)-2-AMINO-N-(2,2-DIETHOXYETHYL)-3-(1,1-DIMETHYLETHOXY)-N-(2-PHENYLETHYL)-PROPANAMIDE, 95.0%, 250mg

1-Ethyl-3-methyl-1H-pyrazol-4-ylamine, 95.0%, 500mg

1,2-DIMETHYL-1H-IMIDAZOLE-5-CARBOXYLIC ACID HCL, 95.0%, 100mg

3-Dimethylaminopiperidine, 98.0%, 1g

4-Bromo-4'-(trifluoromethoxy)biphenyl, 97.0%, 5g

Ethyl 2-Amino-6-methylbenzoate, 97.0%, 1g